| Overview |
| bsm-61951r |
| Lysyl tRNA synthetase Recombinant Antibody |
| WB, IHC-P, IHC-F, IP, IF, ICC/IF |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Lysine tRNA ligase |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 3735 |
| Q15046 |
| CMTRIB; KARS; KARS1; KARS2; KRS; Lysine tRNA ligase; LysRS. |
| Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA.When secreted, acts as a signaling molecule that induces immune response through the activation of monocyte/macrophages. |
| Application Dilution |
| WB |
1:300-5000 |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
| IP |
IFICC1:50-200 |
| IF |
IP1-2ug |
| ICC/IF |
IF |
Powered by Bioz